{
    "code": "01026201",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026201",
    "time": "2020-01-24 03:40:34",
    "許可證字號": "衛署藥製字第026201號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/12\/31",
    "發證日期": "71\/09\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102620102",
    "中文品名": "&quot;東洲&quot;益咳鎮錠２０公絲（伊普拉辛隆）",
    "英文品名": "ECOZINE TABLETS 20MG (EPRAZINONE) &quot;ORIENTAL&quot;",
    "適應症": "下列呼吸器疾患之鎮咳及袪痰、肺炎、支氣管擴張症、支氣管氣喘、急慢性支氣管炎、上氣道炎、感冒",
    "劑型": "110錠劑",
    "包裝": "50.100.200.500.1000粒瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 1R不得製造",
        "申請商名稱": "6231147074  東洲化學製藥廠股份有限公司",
        "申請商地址": "新北市蘆洲區中山二路195巷12號1-2樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800001311",
            "成分名稱": "EPRAZINONE HCL",
            "含量描述": "20",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010262010001仿單-益咳鎮錠(賦)-104-12-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026201&Seq=001&Type=9"
        },
        {
            "title": "010262010002標籤-益咳鎮錠-104-12-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026201&Seq=001&Type=8"
        }
    ]
}